| Pharmacokinetics and drug-drug interactions of lopinavir-ritonavir administered with first-and second-line antituberculosis drugs in HIV-infected children treated for multidrug … LE van der Laan, AJ Garcia-Prats, HS Schaaf, T Tikiso, L Wiesner, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 00420-17, 2018 | 30 | 2018 |
| Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis F Gafar, RE Wasmann, HM McIlleron, RE Aarnoutse, HS Schaaf, ... European Respiratory Journal 61 (3), 2023 | 19 | 2023 |
| Abacavir exposure in children cotreated for tuberculosis with rifampin and superboosted lopinavir-ritonavir H Rabie, T Tikiso, J Lee, L Fairlie, R Strehlau, R Bobat, A Liberty, ... Antimicrobial Agents and Chemotherapy 64 (5), 10.1128/aac. 01923-19, 2020 | 5 | 2020 |
| Acute-on-chronic liver failure alters linezolid pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study T Tikiso, V Fuhrmann, C König, D Jarczak, S Iwersen-Bergmann, S Kluge, ... Annals of Intensive Care 13 (1), 83, 2023 | 2 | 2023 |
| A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model K Iqbal, H Rohde, J Huang, T Tikiso, LF Amann, M Zeitlinger, SG Wicha Journal of Antimicrobial Chemotherapy 77 (9), 2470-2478, 2022 | 2 | 2022 |
| Population pharmacokinetics of ethambutol in African children: a pooled analysis T Tikiso, H McIlleron, MT Abdelwahab, A Bekker, A Hesseling, C Chabala, ... Journal of Antimicrobial Chemotherapy 77 (7), 1949-1959, 2022 | 2 | 2022 |
| Comparison of flavonoid profile and respiratory smooth muscle relaxant effects of Artemisia afra versus Leonotis leonurus T Tikiso University of the Western Cape, 2015 | 2 | 2015 |
| Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications T Tikiso, H McIlleron, D Burger, D Gibb, H Rabie, J Lee, M Lallemant, ... British Journal of Clinical Pharmacology 88 (2), 403-415, 2022 | 1 | 2022 |
| TB/HIV co-treatment with super-boosted lopinavir and anti-tuberculosis treatment lowers abacavir concentration in children H Rabie, T Tikiso, H McIlleron, J Lee, I Andrieux-Meyer, M Cotton, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 21, 121-122, 2018 | 1 | 2018 |
| Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children T Tikiso | | 2021 |
| A pooled analysis of abacavir pharmacokinetics in HIV-infected African children: the effect of age, malnutrition, and common concomitant co-medications T Tikiso, H McIlleron, H Rabie, J Lee, M Archary, S Hennig, M Cotton, ... | | 2019 |
| Pharmacokinetics and drug-drug interactions of lopinavir-ritonavir administered with first-and second-line antituberculosis drugs in HIV-infected children treated for multidrug … LE Laan, AJ Garcia-Prats, HS Schaaf, T Tikiso, L Wiesner, M Kock, ... | | 2018 |
| Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted LopinavirRitonavir T Tikiso, J LEE, H Rabie, L Fairlie, R Strehlau, R Bobat, A Liberty | | |
| Population Pharmacokinetics of Abacavir in HIV-infected African children T Tikiso, A Bienczak, D Gibb, D Burger, H McIlleron, P Denti | | |
| TB/HIV co-treatment with superboosted lopinavir lowers abacavir concentrations in children T Tikiso, H Rabie, H McIlleron, J Lee, I Andrieux-Meyer, M Cotton, ... PAGE 27, 0 | | |
